secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iveda Solutions, Inc. (IVDA)
CIK:        0001397183
Form:       8-K
Filed at:   2026-09-09T12:00:20+00:00
Accession:  0001493152-26-041878
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq grants Iveda 180-day extension to March 1, 2027 to regain $1.00 bid price compliance
--------------------------------------------------------------------------------

- Nasdaq granted additional 180-day period through March 1, 2027 to cure minimum bid price deficiency under Rule 5550(a)(2).
- To regain compliance, IVDA must close at or above $1.00 for at least 10 consecutive business days during the extension.
- Iveda may consider a reverse stock split if needed; no decision announced yet.
- No immediate effect on listing; common stock continues trading on Nasdaq Capital Market under symbol IVDA.
- Company cites commercial progress in AI video intelligence, autonomous systems, and IvedaAir launch during extension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1397183/000149315226041878/0001493152-26-041878-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1397183/000149315226041878/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-041878

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer